Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Total Liabilities 2017–2025
Puma Biotechnology Inc. annual total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Puma Biotechnology Inc. total liabilities as of December 31, 2025: 86.0M, a 29.08% decrease year-over-year.
- Puma Biotechnology Inc. total liabilities for 2025 were 86.0M, a 29.08% decrease from 2024.
- Puma Biotechnology Inc. total liabilities for 2024 were 121.2M, a 31.55% decrease from 2023.
- Puma Biotechnology Inc. total liabilities for 2023 were 177.1M, a 11.66% decrease from 2022.
- Puma Biotechnology Inc. total liabilities for 2022 were 200.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Puma Biotechnology Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $86 |
| 2024 | $121 |
| 2023 | $177 |
| 2022 | $200 |
| 2021 | $229 |
| 2020 | $250 |
| 2019 | $217 |
| 2018 | $225 |
| 2017 | $112 |
Puma Biotechnology Inc. Total Liabilities — FAQ
Puma Biotechnology Inc. (PBYI) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PBYI's total liabilities history?
The chart and table above show Puma Biotechnology Inc.'s total liabilities by year and by quarter, including the growth rate.